img

Global Parkinsons Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Parkinsons Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
Parkinsons Disease Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Parkinsons Disease Drug market is projected to reach US$ 7419.9 million in 2034, increasing from US$ 5492 million in 2022, with the CAGR of 4.3% during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Parkinsons Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Segment by Type
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors

Segment by Application


Hospital
Clinics
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Parkinsons Disease Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Parkinsons Disease Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Parkinsons Disease Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Parkinsons Disease Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Parkinsons Disease Drug introduction, etc. Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Parkinsons Disease Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Parkinsons Disease Drug Market Overview
1.1 Parkinsons Disease Drug Product Overview
1.2 Parkinsons Disease Drug Market Segment by Type
1.2.1 Carbidopa/Levodopa
1.2.2 Dopamine Receptor Agonists
1.2.3 MAO-Inhibitors
1.3 Global Parkinsons Disease Drug Market Size by Type
1.3.1 Global Parkinsons Disease Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Parkinsons Disease Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Parkinsons Disease Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Parkinsons Disease Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Parkinsons Disease Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Parkinsons Disease Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Parkinsons Disease Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Parkinsons Disease Drug Sales Breakdown by Type (2018-2024)
2 Global Parkinsons Disease Drug Market Competition by Company
2.1 Global Top Players by Parkinsons Disease Drug Sales (2018-2024)
2.2 Global Top Players by Parkinsons Disease Drug Revenue (2018-2024)
2.3 Global Top Players by Parkinsons Disease Drug Price (2018-2024)
2.4 Global Top Manufacturers Parkinsons Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Parkinsons Disease Drug Market Competitive Situation and Trends
2.5.1 Parkinsons Disease Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Parkinsons Disease Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Parkinsons Disease Drug Market
2.8 Key Manufacturers Parkinsons Disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Parkinsons Disease Drug Status and Outlook by Region
3.1 Global Parkinsons Disease Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Parkinsons Disease Drug Historic Market Size by Region
3.2.1 Global Parkinsons Disease Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Parkinsons Disease Drug Sales in Value by Region (2018-2024)
3.2.3 Global Parkinsons Disease Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Parkinsons Disease Drug Forecasted Market Size by Region
3.3.1 Global Parkinsons Disease Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Parkinsons Disease Drug Sales in Value by Region (2024-2034)
3.3.3 Global Parkinsons Disease Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Parkinsons Disease Drug by Application
4.1 Parkinsons Disease Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinics
4.1.3 Other
4.2 Global Parkinsons Disease Drug Market Size by Application
4.2.1 Global Parkinsons Disease Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Parkinsons Disease Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Parkinsons Disease Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Parkinsons Disease Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Parkinsons Disease Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Parkinsons Disease Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Parkinsons Disease Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Parkinsons Disease Drug Sales Breakdown by Application (2018-2024)
5 North America Parkinsons Disease Drug by Country
5.1 North America Parkinsons Disease Drug Historic Market Size by Country
5.1.1 North America Parkinsons Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Parkinsons Disease Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Parkinsons Disease Drug Sales in Value by Country (2018-2024)
5.2 North America Parkinsons Disease Drug Forecasted Market Size by Country
5.2.1 North America Parkinsons Disease Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Parkinsons Disease Drug Sales in Value by Country (2024-2034)
6 Europe Parkinsons Disease Drug by Country
6.1 Europe Parkinsons Disease Drug Historic Market Size by Country
6.1.1 Europe Parkinsons Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Parkinsons Disease Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Parkinsons Disease Drug Sales in Value by Country (2018-2024)
6.2 Europe Parkinsons Disease Drug Forecasted Market Size by Country
6.2.1 Europe Parkinsons Disease Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Parkinsons Disease Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Parkinsons Disease Drug by Region
7.1 Asia-Pacific Parkinsons Disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific Parkinsons Disease Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Parkinsons Disease Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Parkinsons Disease Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Parkinsons Disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Parkinsons Disease Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Parkinsons Disease Drug Sales in Value by Region (2024-2034)
8 Latin America Parkinsons Disease Drug by Country
8.1 Latin America Parkinsons Disease Drug Historic Market Size by Country
8.1.1 Latin America Parkinsons Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Parkinsons Disease Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Parkinsons Disease Drug Sales in Value by Country (2018-2024)
8.2 Latin America Parkinsons Disease Drug Forecasted Market Size by Country
8.2.1 Latin America Parkinsons Disease Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Parkinsons Disease Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Parkinsons Disease Drug by Country
9.1 Middle East and Africa Parkinsons Disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa Parkinsons Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Parkinsons Disease Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Parkinsons Disease Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Parkinsons Disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Parkinsons Disease Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Parkinsons Disease Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Teva Parkinsons Disease Drug Products Offered
10.1.5 Teva Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis AG Parkinsons Disease Drug Products Offered
10.2.5 Novartis AG Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GSK Parkinsons Disease Drug Products Offered
10.3.5 GSK Recent Development
10.4 AbbVie
10.4.1 AbbVie Company Information
10.4.2 AbbVie Introduction and Business Overview
10.4.3 AbbVie Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 AbbVie Parkinsons Disease Drug Products Offered
10.4.5 AbbVie Recent Development
10.5 Merck
10.5.1 Merck Company Information
10.5.2 Merck Introduction and Business Overview
10.5.3 Merck Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Merck Parkinsons Disease Drug Products Offered
10.5.5 Merck Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information
10.6.2 Boehringer Ingelheim Introduction and Business Overview
10.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Boehringer Ingelheim Parkinsons Disease Drug Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 Impax Laboratories
10.7.1 Impax Laboratories Company Information
10.7.2 Impax Laboratories Introduction and Business Overview
10.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Impax Laboratories Parkinsons Disease Drug Products Offered
10.7.5 Impax Laboratories Recent Development
10.8 Lundbeck
10.8.1 Lundbeck Company Information
10.8.2 Lundbeck Introduction and Business Overview
10.8.3 Lundbeck Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Lundbeck Parkinsons Disease Drug Products Offered
10.8.5 Lundbeck Recent Development
10.9 Sun Pharma
10.9.1 Sun Pharma Company Information
10.9.2 Sun Pharma Introduction and Business Overview
10.9.3 Sun Pharma Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sun Pharma Parkinsons Disease Drug Products Offered
10.9.5 Sun Pharma Recent Development
10.10 Wockhardt
10.10.1 Wockhardt Company Information
10.10.2 Wockhardt Introduction and Business Overview
10.10.3 Wockhardt Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Wockhardt Parkinsons Disease Drug Products Offered
10.10.5 Wockhardt Recent Development
10.11 UCB
10.11.1 UCB Company Information
10.11.2 UCB Introduction and Business Overview
10.11.3 UCB Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 UCB Parkinsons Disease Drug Products Offered
10.11.5 UCB Recent Development
10.12 Bausch Health
10.12.1 Bausch Health Company Information
10.12.2 Bausch Health Introduction and Business Overview
10.12.3 Bausch Health Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Bausch Health Parkinsons Disease Drug Products Offered
10.12.5 Bausch Health Recent Development
10.13 Acadia
10.13.1 Acadia Company Information
10.13.2 Acadia Introduction and Business Overview
10.13.3 Acadia Parkinsons Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Acadia Parkinsons Disease Drug Products Offered
10.13.5 Acadia Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Parkinsons Disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Parkinsons Disease Drug Industrial Chain Analysis
11.4 Parkinsons Disease Drug Market Dynamics
11.4.1 Parkinsons Disease Drug Industry Trends
11.4.2 Parkinsons Disease Drug Market Drivers
11.4.3 Parkinsons Disease Drug Market Challenges
11.4.4 Parkinsons Disease Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Parkinsons Disease Drug Distributors
12.3 Parkinsons Disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Carbidopa/Levodopa
Table 2. Major Company of Dopamine Receptor Agonists
Table 3. Major Company of MAO-Inhibitors
Table 4. Global Parkinsons Disease Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Parkinsons Disease Drug Sales by Type (2018-2024) & (K Doses)
Table 6. Global Parkinsons Disease Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Parkinsons Disease Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Parkinsons Disease Drug Market Share in Value by Type (2018-2024)
Table 9. Global Parkinsons Disease Drug Price by Type (2018-2024) & (USD/Dose)
Table 10. Global Parkinsons Disease Drug Sales by Type (2024-2034) & (K Doses)
Table 11. Global Parkinsons Disease Drug Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Parkinsons Disease Drug Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Parkinsons Disease Drug Sales Market Share in Value by Type (2024-2034)
Table 14. Global Parkinsons Disease Drug Price by Type (2024-2034) & (USD/Dose)
Table 15. North America Parkinsons Disease Drug Sales by Type (2018-2024) & (K Doses)
Table 16. North America Parkinsons Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Parkinsons Disease Drug Sales (K Doses) by Type (2018-2024)
Table 18. Europe Parkinsons Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Parkinsons Disease Drug Sales (K Doses) by Type (2018-2024)
Table 20. Asia-Pacific Parkinsons Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Parkinsons Disease Drug Sales (K Doses) by Type (2018-2024)
Table 22. Latin America Parkinsons Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Parkinsons Disease Drug Sales (K Doses) by Type (2018-2024)
Table 24. Middle East and Africa Parkinsons Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Parkinsons Disease Drug Sales by Company (2018-2024) & (K Doses)
Table 26. Global Parkinsons Disease Drug Sales Share by Company (2018-2024)
Table 27. Global Parkinsons Disease Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Parkinsons Disease Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Parkinsons Disease Drug Price by Company (2018-2024) & (USD/Dose)
Table 30. Global Parkinsons Disease Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Parkinsons Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Parkinsons Disease Drug Market
Table 34. Key Manufacturers Parkinsons Disease Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Parkinsons Disease Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Parkinsons Disease Drug Sales by Region (2018-2024) & (K Doses)
Table 38. Global Parkinsons Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Parkinsons Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Parkinsons Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 42. Global Parkinsons Disease Drug Sales by Region (2024-2034) & (K Doses)
Table 43. Global Parkinsons Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Parkinsons Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Parkinsons Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 46. Global Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 47. Global Parkinsons Disease Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Parkinsons Disease Drug Sales by Application (2018-2024) & (K Doses)
Table 49. Global Parkinsons Disease Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Parkinsons Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Parkinsons Disease Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Parkinsons Disease Drug Price by Application (2018-2024) & (USD/Dose)
Table 53. Global Parkinsons Disease Drug Sales by Application (2024-2034) & (K Doses)
Table 54. Global Parkinsons Disease Drug Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Parkinsons Disease Drug Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Parkinsons Disease Drug Sales Market Share in Value by Application (2024-2034)
Table 57. Global Parkinsons Disease Drug Price by Application (2024-2034) & (USD/Dose)
Table 58. North America Parkinsons Disease Drug Sales by Application (2018-2024) (K Doses)
Table 59. North America Parkinsons Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Parkinsons Disease Drug Sales by Application (2018-2024) (K Doses)
Table 61. Europe Parkinsons Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Parkinsons Disease Drug Sales by Application (2018-2024) (K Doses)
Table 63. Asia-Pacific Parkinsons Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Parkinsons Disease Drug Sales by Application (2018-2024) (K Doses)
Table 65. Latin America Parkinsons Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Parkinsons Disease Drug Sales by Application (2018-2024) (K Doses)
Table 67. Middle East and Africa Parkinsons Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Parkinsons Disease Drug Sales by Country (2018-2024) & (K Doses)
Table 69. North America Parkinsons Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Parkinsons Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Parkinsons Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Parkinsons Disease Drug Sales by Country (2024-2034) & (K Doses)
Table 73. North America Parkinsons Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Parkinsons Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Parkinsons Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Parkinsons Disease Drug Sales by Country (2018-2024) & (K Doses)
Table 77. Europe Parkinsons Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Parkinsons Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Parkinsons Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Parkinsons Disease Drug Sales by Country (2024-2034) & (K Doses)
Table 81. Europe Parkinsons Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Parkinsons Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Parkinsons Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Parkinsons Disease Drug Sales by Region (2018-2024) & (K Doses)
Table 85. Asia-Pacific Parkinsons Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Parkinsons Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Parkinsons Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Parkinsons Disease Drug Sales by Region (2024-2034) & (K Doses)
Table 89. Asia-Pacific Parkinsons Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Parkinsons Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Parkinsons Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Parkinsons Disease Drug Sales by Country (2018-2024) & (K Doses)
Table 93. Latin America Parkinsons Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Parkinsons Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Parkinsons Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Parkinsons Disease Drug Sales by Country (2024-2034) & (K Doses)
Table 97. Latin America Parkinsons Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Parkinsons Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Parkinsons Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Parkinsons Disease Drug Sales by Country (2018-2024) & (K Doses)
Table 101. Middle East and Africa Parkinsons Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Parkinsons Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Parkinsons Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Parkinsons Disease Drug Sales by Country (2024-2034) & (K Doses)
Table 105. Middle East and Africa Parkinsons Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Parkinsons Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Parkinsons Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 108. Teva Company Information
Table 109. Teva Introduction and Business Overview
Table 110. Teva Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 111. Teva Parkinsons Disease Drug Product
Table 112. Teva Recent Development
Table 113. Novartis AG Company Information
Table 114. Novartis AG Introduction and Business Overview
Table 115. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 116. Novartis AG Parkinsons Disease Drug Product
Table 117. Novartis AG Recent Development
Table 118. GSK Company Information
Table 119. GSK Introduction and Business Overview
Table 120. GSK Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 121. GSK Parkinsons Disease Drug Product
Table 122. GSK Recent Development
Table 123. AbbVie Company Information
Table 124. AbbVie Introduction and Business Overview
Table 125. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 126. AbbVie Parkinsons Disease Drug Product
Table 127. AbbVie Recent Development
Table 128. Merck Company Information
Table 129. Merck Introduction and Business Overview
Table 130. Merck Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 131. Merck Parkinsons Disease Drug Product
Table 132. Merck Recent Development
Table 133. Boehringer Ingelheim Company Information
Table 134. Boehringer Ingelheim Introduction and Business Overview
Table 135. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 136. Boehringer Ingelheim Parkinsons Disease Drug Product
Table 137. Boehringer Ingelheim Recent Development
Table 138. Impax Laboratories Company Information
Table 139. Impax Laboratories Introduction and Business Overview
Table 140. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 141. Impax Laboratories Parkinsons Disease Drug Product
Table 142. Impax Laboratories Recent Development
Table 143. Lundbeck Company Information
Table 144. Lundbeck Introduction and Business Overview
Table 145. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 146. Lundbeck Parkinsons Disease Drug Product
Table 147. Lundbeck Recent Development
Table 148. Sun Pharma Company Information
Table 149. Sun Pharma Introduction and Business Overview
Table 150. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 151. Sun Pharma Parkinsons Disease Drug Product
Table 152. Sun Pharma Recent Development
Table 153. Wockhardt Company Information
Table 154. Wockhardt Introduction and Business Overview
Table 155. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 156. Wockhardt Parkinsons Disease Drug Product
Table 157. Wockhardt Recent Development
Table 158. UCB Company Information
Table 159. UCB Introduction and Business Overview
Table 160. UCB Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 161. UCB Parkinsons Disease Drug Product
Table 162. UCB Recent Development
Table 163. Bausch Health Company Information
Table 164. Bausch Health Introduction and Business Overview
Table 165. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 166. Bausch Health Parkinsons Disease Drug Product
Table 167. Bausch Health Recent Development
Table 168. Acadia Company Information
Table 169. Acadia Introduction and Business Overview
Table 170. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 171. Acadia Parkinsons Disease Drug Product
Table 172. Acadia Recent Development
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Parkinsons Disease Drug Market Trends
Table 176. Parkinsons Disease Drug Market Drivers
Table 177. Parkinsons Disease Drug Market Challenges
Table 178. Parkinsons Disease Drug Market Restraints
Table 179. Parkinsons Disease Drug Distributors List
Table 180. Parkinsons Disease Drug Downstream Customers
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinsons Disease Drug Product Picture
Figure 2. Global Parkinsons Disease Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Parkinsons Disease Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Parkinsons Disease Drug Sales Status and Outlook (2018-2034) & (K Doses)
Figure 5. Product Picture of Carbidopa/Levodopa
Figure 6. Global Carbidopa/Levodopa Sales YoY Growth (2018-2034) & (K Doses)
Figure 7. Product Picture of Dopamine Receptor Agonists
Figure 8. Global Dopamine Receptor Agonists Sales YoY Growth (2018-2034) & (K Doses)
Figure 9. Product Picture of MAO-Inhibitors
Figure 10. Global MAO-Inhibitors Sales YoY Growth (2018-2034) & (K Doses)
Figure 11. Global Parkinsons Disease Drug Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Parkinsons Disease Drug Sales Market Share by Type in 2022 & 2034
Figure 13. North America Parkinsons Disease Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Parkinsons Disease Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Parkinsons Disease Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Parkinsons Disease Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Parkinsons Disease Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Parkinsons Disease Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Parkinsons Disease Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Parkinsons Disease Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Parkinsons Disease Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Parkinsons Disease Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Parkinsons Disease Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Parkinsons Disease Drug Revenue in 2022
Figure 25. Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2034) & (K Doses)
Figure 28. Product Picture of Clinics
Figure 29. Global Clinics Sales YoY Growth (2018-2034) & (K Doses)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2034) & (K Doses)
Figure 32. Global Parkinsons Disease Drug Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Parkinsons Disease Drug Sales Market Share by Application in 2022 & 2034
Figure 34. North America Parkinsons Disease Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Parkinsons Disease Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Parkinsons Disease Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Parkinsons Disease Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Parkinsons Disease Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Parkinsons Disease Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Parkinsons Disease Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Parkinsons Disease Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Parkinsons Disease Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Parkinsons Disease Drug Manufacturing Cost Structure
Figure 45. Parkinsons Disease Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries